Global Metabolomics Market is Expected to get US
The global metabolomics market is expected to be around $2.5 billion by 2025. Increase in demand for personalized medicines, rapid development in pharmaceutical and biotech sectors, increase in prevalence of target diseases, and rising demand for toxicology technologies are major factors contributing to the market growth. However, high cost of associated instruments and tools, unwillingness to adopt advanced technology for data processing by traditional professionals and dearth of skilled workforce can impact the growth of the market
The global metabolomics market is expected to be around $2.5 billion by 2025. Increase in demand for personalized medicines, rapid development in pharmaceutical and biotech sectors, increase in prevalence of target diseases, and rising demand for toxicology technologies are major factors contributing to the market growth. However, high cost of associated instruments and tools, unwillingness to adopt advanced technology for data processing by traditional professionals and dearth of skilled workforce can impact the growth of the market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The global metabolomics market <strong>is</strong> expected <strong>to</strong> be around $2.5 billion by 2025. Increase<br />
in demand for personalized medicines, rapid development in pharmaceutical and biotech<br />
sec<strong>to</strong>rs, increase in prevalence of tar<strong>get</strong><br />
d<strong>is</strong>eases, and r<strong>is</strong>ing demand for <strong>to</strong>xicology<br />
technologies are major fac<strong>to</strong>rs contributing <strong>to</strong> the<br />
market growth. However, high cost of associated<br />
instruments and <strong>to</strong>ols, unwillingness <strong>to</strong> adopt<br />
advanced technology for data processing by<br />
traditional professionals and dearth of skilled<br />
workforce can impact the growth of the market.<br />
Major <strong>Market</strong> Players<br />
‣ LECO Corporation<br />
‣ Bio-Rad Labora<strong>to</strong>ries Inc.<br />
‣ Human Metabolome Technologies Inc.<br />
‣ Thermo F<strong>is</strong>her Scientific Inc.<br />
‣ Biocrates Life Sciences AG<br />
‣ Shimadzu Corporation<br />
‣ Agilent Technologies Inc.<br />
‣ Waters Corporation<br />
‣ Metabolon Inc.<br />
‣ Bruker Corporation<br />
Get Sample of Report: http://www.crystalmarketresearch.com/report-sample/HC0635<br />
<strong>Metabolomics</strong>’
<strong>Market</strong> Opportunities<br />
<strong>Metabolomics</strong> <strong>is</strong> gaining high importance in life sciences research owing <strong>to</strong> its systematic<br />
and prec<strong>is</strong>e technique <strong>to</strong> gain vital insights about biological systems. The future<br />
opportunities for metabolomics market lie in development of advanced products with<br />
enhanced stat<strong>is</strong>tical and analytical capabilities.<br />
<strong>Metabolomics</strong> <strong>Market</strong> Segmentation<br />
By Technique:<br />
<br />
Separation Techniques<br />
o<br />
o<br />
o<br />
o<br />
Capillary Electrophores<strong>is</strong><br />
High Performance Liquid Chroma<strong>to</strong>graphy<br />
Gas Chroma<strong>to</strong>graphy<br />
Ultra-Performance Liquid Chroma<strong>to</strong>graphy<br />
<br />
Detection Techniques<br />
o<br />
o<br />
Nuclear Magnetic Resonance Spectroscopy<br />
Mass Spectrometry<br />
By Application:<br />
<br />
<br />
<br />
<br />
<br />
Drug Assessment<br />
Nutrigenomics<br />
Clinical <strong>to</strong>xicology<br />
Biomarker D<strong>is</strong>covery<br />
Others<br />
Get Cus<strong>to</strong>mized Report: http://www.crystalmarketresearch.com/cus<strong>to</strong>mization/HC0635<br />
1. Introduction<br />
2. Executive Summary<br />
3. <strong>Market</strong> Overview<br />
3.1. Introduction<br />
3.1.1. <strong>Market</strong> Definition
3.1.2. <strong>Market</strong> Segmentation<br />
3.2. <strong>Market</strong> Share Analys<strong>is</strong><br />
3.3. <strong>Market</strong> Dynamics<br />
3.3.1. Drivers<br />
3.3.1.1. R<strong>is</strong>ing Demand for Personalized Medicines<br />
3.3.1.2. Increase in Prevalence of Tar<strong>get</strong> D<strong>is</strong>eases<br />
3.3.1.3. Rapid Development in Pharmaceutical and Biotech Sec<strong>to</strong>rs<br />
3.3.2. Restraints<br />
3.3.2.1. High Cost of Instruments<br />
3.3.2.2. Dearth of Skilled Professionals<br />
3.3.3. Opportunities<br />
3.3.3.1. Emerging <strong>Market</strong> <strong>to</strong> Offer Lucrative Growth Opportunities<br />
3.4. Industry Trends<br />
3.5. Reimbursement Scenario<br />
4. <strong>Metabolomics</strong> <strong>Market</strong>, By Technique<br />
Buy Report: http://www.crystalmarketresearch.com/checkout/HC0635<br />
5. <strong>Metabolomics</strong> <strong>Market</strong>, By Application<br />
6. <strong>Metabolomics</strong> <strong>Market</strong>, By Region<br />
7. Company Profiles<br />
<strong>Metabolomics</strong>
About Crystal <strong>Market</strong> Research<br />
Crystal <strong>Market</strong> Research <strong>is</strong> a U.S. based market research and business<br />
intelligence company. Crystal offers one s<strong>to</strong>p solution for market research,<br />
business intelligence, and consulting services <strong>to</strong> help clients make more<br />
informed dec<strong>is</strong>ions. It provides both syndicated as well as cus<strong>to</strong>mized research<br />
studies for its cus<strong>to</strong>mers spread across the globe. The company offers market<br />
intelligence reports across a broad range of industries including healthcare,<br />
chemicals & materials, technology, au<strong>to</strong>motive, and energy.<br />
Contact Us:<br />
304 South Jones Blvd, Suite 1896,<br />
Las Vegas NV 89107,<br />
United States<br />
Toll Free: + 1-888-213-4282
Email: sales@crystalmarketresearch.com<br />
Website: www.crystalmarketresearch.com
Change language